Edgewise Therapeutics
Biotechnology ResearchColorado, United States51-200 Employees
Edgewise Therapeutics, Inc., (NASDAQ: EWTX), is a leading muscle disease biopharmaceutical company developing novel therapeutics for muscular dystrophies and serious cardiac conditions.